CVE-2021-43094

CVE-2021-43094 is a critical-severity vulnerability in Openmrs with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Description

An SQL Injection vulnerability exists in OpenMRS Reference Application Standalone Edition <=2.11 and Platform Standalone Edition <=2.4.0 via GET requests on arbitrary parameters in patient.page.

Frequently asked questions

What is CVE-2021-43094?
An SQL Injection vulnerability exists in OpenMRS Reference Application Standalone Edition <=2.11 and Platform Standalone Edition <=2.4.0 via GET requests on arbitrary parameters in patient.page.
How severe is CVE-2021-43094?
CVE-2021-43094 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2021-43094 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (65th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2021-43094?
CVE-2021-43094 primarily affects Openmrs. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2021-43094?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2021-43094 published?
CVE-2021-43094 was published on 2022-05-10 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Openmrs

All CVEs affecting Openmrs →

Other CWE-89 (SQL Injection) vulnerabilities

Browse all CWE-89 (SQL Injection) vulnerabilities →